July 2012

Applications are invited upto 28th July 2012 for one post of Scientist ‘C’ (Organic Chemistry / Natural Product Chemistry) in the Pay Band PB-3 Rs.15600-39100 + Grade Pay Rs. 6600/- at the ICMR's Regional Medical Research Centre, Belgaum.

Post: Scientist C

Indian Institute of Science Education and Research Bhopal was created in 2008 by the Ministry of Human Resource Development, Government of India. Its mission is to provide quality science education to UG and PG students.

ABOUT AUTHORS:
¹ Shashi Kant^*,Satinder Kumar, Rajender Kumar,
Research scholar department of pharmacy.
² Dr. Bharat Prashar
HOD & Associate professor  Department of Pharmaceutical Sciences, Manav Bharti University, Solan (H.P)
* shashi_ranaute@yahoo.in

ABSTRACT:-
In this review article, we discussed about Bioavailability and bioequilance study, bioavailability means rate and extent to which active ingredients absorbed from a drug product and become available at site of action. This article provides the information about important aspect involved in bioequivalence and regulatory requirement for bioequivalence study. The rate or rapidity at which drug is absorbed is important consideration in treatment of acute conditions such as asthma attack in pain. Extent of absorption is of special significance in treatment of chronic conditions like hypertension, epilepsy. In this review we discussed all the factors affecting bioavailability from its dosage form, objective/purpose of bioavailability study, design and evaluation of bioequilance study, methods of assessing of bioavailability and bioequilance etc.

Applications must be submitted online through the official website of the Commission after 'ONE TIME REGISTRATION' .Candidates who have already registered can apply through their profile.

Department : Kerala Drugs Control

Translational Health Science and Technology Institute (THSTI) an initiative of Department of Biotechnology, Government of India and International AIDS Vaccine Initiative (IAVI), USA are seeking Principal Investigators for their new joint collaborative program to accelerate and advance HIV vaccine research and development.

The Himalaya Drug Company was founded in 1930 by Mr. M. Manal with a clear vision to bring Ayurveda to society in a contemporary form and to unravel the mystery behind the 5,000 year old system of medicine. This included referring to ancient ayurvedic texts, selecting indigenous herbs and subjecting the formulations to modern pharmacological, toxicological and safety tests to create new drugs and therapies.